VC Fund Dossiers

360 Capital is one of Europe's most successful old-school VC shops that actually delivers results—their Preligens exit to Safran for €220M in 2024 and backing Exotec to become France's first industrial unicorn proves they know how to pick winners and get liquidity. Founded in 1997, they've survived multiple cycles and have the conviction to back deep tech when others chase software. Fausto Boni is a genuine operator with McKinsey pedigree who sits on boards and gets his hands dirty. The dual Paris-Milan setup gives them unique access to Southern European talent that coastal VCs miss. Their 71% seed to Series A conversion rate (92% including exits) is exceptional. Watch for their climate tech focus with the new €140M 360 LIFE II fund—they're betting big on energy transition when others just talk about it.

3M Ventures is the rare corporate VC that actually knows what they're talking about when it comes to deep tech and manufacturing. They bring genuine technical expertise and can open doors to pilot programs with 3M's massive industrial customer base. The flip side? They move at corporate speed, decisions take forever, and there's always the strategic acquisition shadow hanging over everything. If your tech genuinely complements 3M's business, they're incredibly valuable partners. If not, you're probably better off with traditional VCs who won't spend six months debating internal synergies.

AEI HorizonX is basically Boeing's venture arm trying to act like a Silicon Valley fund, which creates some interesting dynamics. They have genuine aerospace expertise and can open doors that traditional VCs can't, but they move at aerospace industry speed (read: glacially slow). Their partners know the space cold and can help navigate regulatory nightmares, but don't expect quick decisions or Silicon Valley-style risk tolerance. They're particularly useful if you need intros to OEMs or help with certification processes, less useful if you need fast capital or aggressive growth strategies.

AlbionVC is the grown-up in the room of UK venture - they've been doing this since 1996 and it shows in their disciplined, thesis-driven approach. Their partners project an aura of patience and take a genuinely long-term view, with reputation and consistency carrying more weight than flashy deals. Founders consistently praise Ed Lascelles specifically - Tony Pepper from Egress called him "equally important" to their success alongside the team and tech, while Quantexa's CEO said they've been privileged to work with Ed and AlbionVC from the beginning. They actually stick around - Quantexa went from first investment in 2017 to a $175m Series F at $2.6bn valuation in 2025, with AlbionVC participating in every round. The downside? They're not going to move fast on trendy deals, and if you want VC theater or ego stroking, look elsewhere.

Amadeus is one of the rare VCs that actually walks the walk on deep tech—they've been at it since 1997 when most funds were still figuring out what the internet was. As one founder, whose startup ContactEngine was acquired by NICE Systems, put it, landing investment from Amadeus meant securing one of "the best VCs in our space." Hermann Hauser's track record speaks for itself (he basically created ARM), and Anne Glover has built this into a proper institution. They are active investors who commonly take board seats and provide strategic advice, recruitment support, and introductions to international networks and corporate partners. The firm prides itself on being supportive yet measured, understanding when to step back and let the founders steer their company. The exit track record is genuinely impressive—multiple billion-dollar outcomes across different cycles. But here's the rub: they're extremely technical and will grill you hard on IP and defensibility. founders should be prepared for rigorous technical due diligence from Amadeus's experienced partners, many of whom bring a deep scientific background themselves.

This is Amazon's strategic arm masquerading as a VC fund - they're shopping for acquisition targets and ecosystem partners, not just financial returns. If your startup has Amazon synergies, they can be incredibly valuable with distribution, AWS credits, and Alexa integration support. But founders should know they're essentially auditing for Amazon - expect deep technical due diligence and be prepared for acquisition pressure if you succeed. The team knows voice tech cold and has real operational chops, but this isn't independent capital. They move slowly on decisions and everything gets filtered through Amazon's broader strategic priorities.

Applied Ventures is the strategic arm of a $60B semiconductor equipment giant, which means they have real money and genuine industry connections that can open doors. The good news: if you're building something that touches chip manufacturing, they actually understand the space and can provide real technical validation plus introductions to every major fab. The reality check: this is corporate venture capital at its most corporate - expect longer decision cycles, internal politics affecting your deal, and strategic considerations that may not align with pure financial returns. They're genuinely helpful for hardware startups needing manufacturing partnerships, but software companies often find the relationship less valuable than promised.

Armilar is the real deal - they've backed three unicorns (OutSystems, Feedzai, Sword Health) and have genuine deep-tech credibility spanning 25+ years. Their track record of generating returns is grounded on backing founders throughout their journey, not just writing checks. However, they work on 16 percentage points less than the average amount of lead investments, meaning they're selective but might not always lead your round. The fact they successfully raised €120M in 2025's brutal fundraising environment speaks volumes about LP confidence in their returns. The senior team has been working together for a decade with 60+ years of cumulative VC experience - this isn't a new fund with untested dynamics.

Austral Capital is essentially a one-person show built around Gonzalo Miranda's extensive Chilean business network. Miranda's Endeavor background gives him serious founder credibility, but this fund has been notably quiet for a decade - their "latest" portfolio company data from most sources is 2012-2015. The recent Zonox investment in late 2024 suggests they're back in action, but with just $200M AUM over 16 years and two exits in 2022, this feels more like a boutique family office than an active VC. The Warburg Pincus exit shows they can deliver returns, but founders should expect a very hands-on, network-heavy approach typical of smaller regional funds. Good for Chilean founders who value deep local connections over fast capital deployment.

Autotech is the rare mobility-focused fund that actually understands both the tech and the brutal realities of the auto industry. Their partners have real operational experience, not just consulting backgrounds, which matters when you're trying to sell to Ford or navigate DOT regulations. The flip side is they can be overly cautious about consumer-facing mobility plays and sometimes overthink the corporate development angle. They're genuinely helpful post-investment with introductions to OEMs and industry veterans, but don't expect them to move fast on decisions.

Axon is that rare breed - a publicly traded VC (BME: APG) with €685 million AUM that actually knows what they're doing. With 1 unicorn (Forto), 7 IPOs, and 11 acquisitions in their portfolio, they've got the track record to back up the hype. The dual consulting-investment model is either genius or a distraction - it gives them deep sector insights but might split focus. Francisco Velazquez landing on the EU Innovation Council board shows they have serious Brussels connections, which matters for regulatory-heavy sectors. They're heavy on Spain/Southern Europe but expanding globally, so perfect if you're a Spanish startup needing local expertise and international ambitions. The climate tech push feels authentic given their track record, not just trend-chasing.

This is the Bertelsmann money machine with Chinese characteristics - Annabelle Long built one of China's most successful VC franchises from scratch and it shows. Since 2008, she's led the team to achieve more than 18 IPOs and more than 40 unicorns, including Linklogis, Lexin, NetEase Cloud Music, SF Intra-City, Stori, Keep, PingCAP, Mobike, and others. The Bertelsmann backing gives them patient capital and global network access that pure financial VCs can't match. They're genuinely good at spotting Chinese companies that can scale globally - see Stori becoming Mexico's newest unicorn. Long is old-school media savvy (started as a TV anchor) which translates to strong founder relationships and board presence. The downside? They're betting heavily on China-to-global expansion at a time when geopolitical headwinds are only getting stronger, and their sweet spot might be getting squeezed by rising US-China tensions.

Bayern Kapital operates as a co-investor alongside private investors, adhering to the pari-passu principle, and typically holds minority stakes. We invest according to the pari-passu principle. In the case of a financing round, this means that all parties involved are treated equally and must invest the same amount of capital as Bayern Kapital. This is both their strength and potential limitation - they're patient, government-backed capital that won't push for quick exits, but they require private lead investors to move. With 3 unicorns (IQM, Quantum Systems, EGYM) and strong exits like MorphoSys, they clearly pick winners, but their bureaucratic structure means slower decisions than pure private funds. Their 8-10 year investment horizons and €700M+ AUM make them ideal for deep tech that needs patient capital, but expect more process and committees than your typical VC.

Big Pi is the real deal in the Greek/diaspora space - they're not just tourist money but serious operators with legit exits under their belt (Accusonus to Meta for €70-100M). The team brings actual entrepreneurial chops: Marco built Upstream to €230M revenue, Nick was at Prime Ventures doing serious European deals, and Alex literally helped create the Python data science stack. They require portfolio companies to maintain substantial Greek operations, which is both a feature (cheap talent, government support) and potential bug (geographic constraint). Their "tech-first" mandate with IP requirements means they actually understand what defensible tech looks like, unlike funds that chase flashy B2C plays.

BMW i Ventures is corporate VC done reasonably well — they actually write meaningful checks and their automotive expertise is legit, not just marketing fluff. The catch? They move at BMW speed, which means glacial decision-making and endless internal approvals. If you need fast capital or hate corporate bureaucracy, look elsewhere. But if you're building something that could benefit from BMW's manufacturing scale, distribution channels, or automotive relationships, they're worth the wait. Just don't expect Silicon Valley-style quick decisions or hands-off investing — they want strategic alignment and will ask lots of questions about how your tech fits their roadmap.

This is the corporate VC arm of a massive government consulting firm, which is both their superpower and their limitation. They're incredibly well-connected in federal circles and can open doors that traditional VCs simply can't touch. Portfolio companies get access to Booz Allen's 29,000+ employees and deep government relationships. However, they're not your typical Silicon Valley fund - they think in government timelines, move more cautiously, and their investment committee includes corporate stakeholders who may not understand startup urgency. Great if you're building dual-use tech and need government validation, but don't expect the same hustle mentality as pure-play VCs.

Bosch Ventures is the real deal if you need an industrial giant's resources behind you, but don't expect typical VC speed or risk appetite. They move deliberately and want clear strategic value for Bosch, not just financial returns. The upside is massive - access to Bosch's 400,000+ employees, manufacturing expertise, and global customer base can accelerate B2B startups like crazy. The downside is corporate venture bureaucracy and they'll push hard for commercial partnerships that may not always align with your broader strategy. Great for hardware and deep tech companies that need patient capital and industrial know-how.

This is France's sovereign wealth fund playing VC - which means they have deeper pockets and longer patience than most, but also means they're not purely profit-driven. They offer unique convertible options that match private investment up to €250k with non-dilutive support, which founders love because it makes them more attractive to other investors. Their strategy is explicitly to create an 'entrepreneur friendly ecosystem' and develop France's VC industry to attract international money. The downside? Some French tech veterans like Ledger's co-founder argue that state backing has propped up fragile business models and created a 'perfusion economy' that masks underlying weaknesses. But founders consistently praise their operational involvement, strategic introductions, and commercial synergies that lead to 'decisive contracts.'

This is Spain's establishment VC - they're the corporate venture arm of CriteriaCaixa, which manages over €25 billion and is backed by la Caixa Foundation. They've been around since 2007 and have made 300+ investments, so they know what they're doing, but they're also exactly what you'd expect from a big Spanish bank's VC arm. The good news: they have serious capital staying power, they actually stick around for follow-on rounds, and they exit 20% more often than average. The reality check: they're not exactly known for being the fastest movers or most founder-friendly when it comes to terms. New CEO Jordi Ros comes from 20 years of traditional corporate finance, not startup-land.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

Capricorn is the rare European VC that actually walks the walk on deep tech and sustainability—they've been doing cleantech since 2007, way before it was cool again. With 2 unicorns (Electric Hydrogen and Xanadu) in their portfolio and a track record spanning 26 years, they're not just another generalist fund pretending to understand hard science. Jos Peeters is a proper physics PhD who's been in the game for over three decades and built the European VC infrastructure we know today. The team genuinely gets technical due diligence, but here's the catch: they're very Belgian in their approach—methodical, relationship-focused, and not flashy. They invest mostly in Belgium (28 companies) and Netherlands (9 companies), so if you're not in their geographic sweet spot or willing to relocate there, you might find yourself on the outside looking in.

This is classic corporate VC - they have real money and industry expertise, but everything runs through the lens of 'could Caterpillar acquire this or become a customer?' They're genuinely helpful if you're building something that fits their industrial wheelhouse, with solid connections and pilot opportunities. The downside is they move at big company speed and every investment decision gets filtered through corporate strategy priorities. Don't expect them to lead rounds or move fast, but they're solid follow-on investors who actually understand heavy industry pain points.

CDIB is Taiwan's legacy PE giant trying to evolve into a modern institutional player - think of them as the KKR of Taiwan, but with more government ties and less global polish. William Ho's CVC pedigree is legit and they've got serious capital ($25B+ AUM), but this is fundamentally a relationship-driven, Taiwan-centric shop that happens to have some Silicon Valley exposure. The 'China Plus' strategy sounds fancy but really means 'help Taiwanese companies expand to China and vice versa.' They're conservative, well-connected in Asia, and have genuine operational expertise in traditional industries, but don't expect the cutting-edge thesis or hands-on value creation you'd get from top-tier US funds. If you're building in hardware, manufacturing, or need Asia expansion, they're solid. If you're doing pure software or need Silicon Valley connections, look elsewhere.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.

DCVC is the rare fund that actually understands deep tech beyond the buzzwords — these guys can evaluate your algorithm and your go-to-market strategy with equal sophistication. They're genuinely helpful post-investment, especially if you're navigating complex enterprise sales cycles or regulatory approval processes. The downside? They have very high technical bars and can be slow to move if they're not immediately convinced of your computational moat. Don't pitch them unless you have serious IP or algorithmic differentiation — they'll smell BS from a mile away.

Decisive Point is the fund you want if you're building for government or heavily regulated markets — they actually understand these sales cycles and have the relationships to help. Schroeder and Janke bring real operational experience, not just check-writing credentials. The downside? Their portfolio focus is narrow, so if you're building consumer or traditional SaaS, look elsewhere. They're also relatively small, so don't expect the brand recognition or downstream fundraising pull of a tier-one fund. But for the right founder in their wheelhouse, they punch above their weight on value-add.

DTC claims 95th percentile returns performance compared to early-stage VC firms - that's either the real deal or excellent marketing. The corporate VC advantage here is real: they're connected to Dell's massive enterprise platform with Fortune 1000 customers, world-class technologists, and partnerships. Founders consistently praise their enterprise sales knowledge and ability to land large customers through Dell introductions in early days. No dedicated fund size gives them flexibility on check size and stage, they've invested $1.8B across 165 companies, make 15-16 new investments annually. The downside of corporate VC applies: they're ultimately strategic investors serving Dell's interests, not just financial returns, so expect them to push for partnerships and integrations that benefit the mothership.

Here's the uncomfortable truth: Discovery Capital is essentially a zombie fund. Their main vehicle, BC Discovery Fund, is in voluntary liquidation with shareholders having approved the windup, and their website shows an 'under construction' page. While they claim big exits like Spotify and Cardlytics, the reality is their remaining portfolio company Phemi has 'no possibility of material realization' with debts exceeding assets. The founders have decades of experience and genuine relationships in the Canadian tech scene, but this isn't an active fund you can realistically pitch - it's winding down operations and liquidating assets.

This isn't really a VC fund in the traditional sense - it's Dow Chemical's strategic checkbook with a venture capital facade. They've made 117 investments since 1994, but every single deal has to somehow benefit Dow's massive industrial empire. Think of them as corporate development with extra steps. The upside? They bring real industrial expertise, manufacturing scale, and can actually help you commercialize hard tech that requires serious operational know-how. The downside? Your startup better align perfectly with Dow's strategic priorities, or you're not even getting a meeting. They're not chasing unicorns or market returns like traditional VCs - they're shopping for technologies that make Dow's chemicals business more competitive.

Earlybird is one of Europe's genuine OG funds that's earned its stripes the hard way - they've been around since 1997 and have the exits to prove it. Their track record speaks volumes: early backer of UiPath (Europe's largest IPO ever), N26, and Aleph Alpha. What founders need to know is that this isn't just another check-writer - they genuinely get involved post-investment and have built serious operational expertise over 28 years. The recent restructuring shows they're not afraid to evolve and focus where they can add the most value. However, they're getting bigger and more institutionalized, which means longer decision cycles and more process than scrappy early-stage funds. They're also heavily Germanic in their approach - methodical, thorough, but sometimes slower to move than Silicon Valley-style funds.

Eclipse isn't just another hardware fund — they're ex-operators who actually know what it takes to scale physical businesses. Greg Reichow literally built Tesla's manufacturing from scratch, and Lior survived the trenches at Flex before starting Eclipse. They don't just write checks; founders consistently praise them as 'true co-founders' who provide deep industry access and operational guidance. Their $1.2B Fund V shows they have serious firepower, but the real differentiator is their willingness to lead large rounds ($350M in Redwood Materials) and stick with companies through multiple follow-ons. The downside? They're picky as hell and focused on a narrow thesis, so if you're not solving a massive physical industry problem with serious technical moats, don't bother.

Elaia is one of the rare European VCs that actually delivers on deep tech promises - they've built 3 unicorns (SandboxAQ, Shift Technology, Mirakl) and had legitimate exits like Criteo's $1.7B NASDAQ IPO and Teads' acquisition by Altice. Xavier Lazarus sits on boards and stays engaged post-investment, which founders consistently praise. The Lazard partnership (with minority stake and option to buy up to 100%) gives them serious growth capital firepower beyond typical VC constraints. However, one employee review noted they can lack operational character and become repetitive - potentially signaling they're better at picking winners than rolling up sleeves in the trenches. They're genuinely technical (math PhD founders) but watch for over-intellectualizing vs. practical market execution.

EIP is the utility-industrial complex's favorite VC, and that's exactly why it works. Built around a coalition of large utilities and energy companies that actively collaborate to give portfolio companies direct access to decision-makers across dozens of operators, this isn't your typical Silicon Valley fund. They closed their latest flagship fund at $1.3 billion in October 2025 while others struggled, proving corporate LPs still have appetite for energy tech when there's real customer validation. The downside? This corporate backing can make them slower than pure financial VCs, and their utility partners sometimes become competitive threats to portfolio companies. But if you're building hard infrastructure tech that needs utility pilots to prove market fit, EIP's Rolodex is unmatched.

Entrée is what happens when actual operators build a VC fund - and it shows in their portfolio performance. With offices in Israel, UK, and the US, Entrée Capital has realized 30 exits and IPOs and its portfolio has 18 unicorns. Avi Eyal's track record speaks for itself: he's the guy who led monday.com from seed to $8B+ IPO and got Amazon to pay hundreds of millions for PillPack. Unlike many VCs who just write checks, this team actually helps founders build companies - they have operational DNA from being serial entrepreneurs themselves. The downside? They can be picky to the point of being almost arrogant about what constitutes "exceptional" founders, and their Israeli roots mean they have strong opinions about how things should be done.

Flagship isn't your typical VC—they're a biotech factory that happens to have a fund attached. Afeyan runs it like a scientific dictatorship where he's the principal founder of everything, which means less dilution but also means you're not really the founder, you're more like a well-funded employee. They'll give you $50M+ and an army of PhDs but expect total control and board dominance. The upside? Unmatched operational support and pharma connections. The downside? You're building Noubar's vision, not yours. They've created genuine category-defining companies (hello Moderna), but founders sometimes feel like highly paid researchers rather than entrepreneurs. If you want to be coddled through biotech company building and don't mind giving up founder control, Flagship is unbeatable. If you want to build your own empire, look elsewhere.

Flagship isn't your typical VC — they're more like a biotech production factory with Noubar Afeyan as the chief mad scientist. They file about 700 patents a year and have created 118 companies with a systematic "what if" approach. The upside? Twenty-five Flagship companies have completed IPOs since 2013, demonstrating exceptional exit performance. The reality check? Industry insiders whisper about reputation issues, with employee reviews citing "culture of extreme paranoia and secrecy" and Associates who "fully drank the Theranos 'image above science' Kool Aid." They position themselves as "principal founder rather than a traditional investor," meaning they'll want significant control and board seats. If you're comfortable with Flagship essentially running your company while you execute their scientific vision, the track record speaks for itself. If you want to be captain of your own ship, look elsewhere.